⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL626538 | 1.00 | — | — | |
| SCHEMBL4077 | 1.00 | — | — | |
| SCHEMBL23151989 | 0.96 | — | — | |
| SCHEMBL181346 | 0.77 | — | — | |
| SCHEMBL76041 | 0.75 | — | — | |
| Hydrogen Sulfide SCHEMBL28797397 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL27868973 | 0.73 | — | — | |
| Ammonia Solution, Strong SCHEMBL30978376 | 0.73 | — | — | |
| SCHEMBL30978372 | 0.73 | — | — | |
| SCHEMBL27938586 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024126517-A1 | CELL-BINDING MOTIFS (CBMs) FUNCTIONALIZED POLYMERS | UNIVERSITEIT GENT (BE) | 2024-06-20 | — | — | WO | disclosed |
| EP-4341321-A1 | CROSSLINKED BIORESORBABLE POLYESTER NETWORKS | Universiteit Gent (BE) | 2024-03-27 | — | — | EP | disclosed |
| US-20230126352-A1 | MACROCYCLIC RIP2-KINASE INHIBITORS | ONCODESIGN SA (FR) | 2023-04-27 | — | — | US | disclosed |
| WO-2023052468-A1 | NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF PARASITIC INFECTIONS | UNIVERSITEIT ANTWERPEN (BE) | 2023-04-06 | — | — | WO | disclosed |
| US-11608326-B2 | Synthetic receptors for ionophoric compounds | UNIVERSITEIT GENT (BE) | 2023-03-21 | — | — | US | disclosed |
| EP-4097110-A1 | MACROCYCLIC RIP2-KINASE INHIBITORS | Oncodesign S.A. (FR) | 2022-12-07 | — | — | EP | disclosed |
| US-20220169604-A1 | BIOCONJUGATION REAGENT AND METHODS | UNIVERSITEIT GENT (BE) | 2022-06-02 | — | — | US | disclosed |
| EP-3180003-B1 | PKC-EPSILON INHIBITORS | UNIV CALIFORNIA (US) | 2022-01-12 | — | — | EP | disclosed |
| EP-3930758-A2 | 2-HYDROXYPYRROLIDIN-5-ONES FOR BIOCONJUGATION AND METHODS FOR THEIR PRODUCTION | Universiteit Gent (BE) | 2022-01-05 | — | — | EP | disclosed |
| WO-2021152165-A1 | MACROCYCLIC RIP2-KINASE INHIBITORS | ONCODESIGN S.A. (FR) | 2021-08-05 | — | — | WO | disclosed |
| EP-0912559-B1 | FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LTD (GB) | 2002-11-06 | — | — | EP | disclosed |
| US-20020147214-A1 | Heterocyclic compounds | NOVARTIS AG (CH) | 2002-10-10 | — | — | US | disclosed |
| US-6391874-B1 | ANTICARCINOGENIC AGENTS; SKIN DISORDERS | SMITHKLINE BEECHAM CORPORATION | 2002-05-21 | — | — | US | disclosed |
| US-6174889-B1 | PROTEIN TYROSINE KINASE INHIBITORS RELATED TO BIOISOSTERES OF QUINOLINE AND QUINAZOLINE DERIVATIVES; ANTICARCINOGENIC AND -TUMOR AGENTS; PSORIASIS; RESTENOSIS; RHEUMATOID ARTHRITIS, AUTOIMMUNE DISEASE, ALLERGY, ASTHMA AND GRAFT REJECTION | GLAXO WELLCOME INC. | 2001-01-16 | — | — | US | disclosed |
| EP-0912559-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1999-05-06 | — | — | EP | disclosed |
| EP-0912570-A1 | BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1999-05-06 | — | — | EP | disclosed |
| EP-0843671-A1 | HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLAXO GROUP LIMITED (GB) | 1998-05-27 | — | — | EP | disclosed |
| WO-1998002438-A1 | BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1998-01-22 | — | — | WO | disclosed |
| WO-1998002434-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1998-01-22 | — | — | WO | disclosed |
| WO-1997003069-A1 | HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLAXO GROUP LIMITED (GB) | 1997-01-30 | — | — | WO | disclosed |